Andrew Lees (vaccinologist)
Andrew Lees (born February 1953 in Massachusetts, United States) is an American vaccine chemist known for developing the CDAP conjugation method, used in vaccines manufactured by GlaxoSmithKline (Streptococcus pneumonia, Neisseria meningiditis ) and conjugate vaccines currently in clinical development by the Serum Institute of India and Chengdu Institute of Biological Products. Currently, Andrew Lees holds 25 patents in the area of conjugate vaccines.
Wikipage disambiguates
primaryTopic
Andrew Lees (vaccinologist)
Andrew Lees (born February 1953 in Massachusetts, United States) is an American vaccine chemist known for developing the CDAP conjugation method, used in vaccines manufactured by GlaxoSmithKline (Streptococcus pneumonia, Neisseria meningiditis ) and conjugate vaccines currently in clinical development by the Serum Institute of India and Chengdu Institute of Biological Products. Currently, Andrew Lees holds 25 patents in the area of conjugate vaccines.
has abstract
Andrew Lees (born February 195 ...... he area of conjugate vaccines.
@en
birth date
birth place
profession
thumbnail
Wikipage page ID
49,290,674
Wikipage revision ID
730,986,030
field
known for
Developing the CDAP conjugation method
nationality
occupation
Vaccine chemist
work institutions
Fina Biosolutions
hypernym
comment
Andrew Lees (born February 195 ...... he area of conjugate vaccines.
@en
label
Andrew Lees (vaccinologist)
@en
wasDerivedFrom
depiction
gender
male
@en
givenName
Andrew
@en
isPrimaryTopicOf
name
Andrew Lees
@en
Dr. Andrew Lees
@en
surname
Lees
@en